WSL
AGN

Western Standard LLC’s Allergan plc AGN Stock Holding History

Western Standard LLC’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-146,558
Closed -$26M – 36
2020
Q1 		$26M Buy
+146,558
New +$27.6M 23.96% 1

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Western Standard LLC's AGN Position: Q2 2020 in Review

Western Standard LLC sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 146,558 shares — an estimated $26M sold.

Western Standard LLC first reported a position in AGN in Q1 2020 and held it in 1 quarter. The position peaked at $26M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Western Standard LLC reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Western Standard LLC sold 146,558 Allergan plc shares in Q2 2020, an estimated $26M.
  • Western Standard LLC first reported a position in Allergan plc in Q1 2020 and held it in 1 quarter.
  • Western Standard LLC's Allergan plc position peaked at $26M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Western Standard LLC's 13F filing for Q2 2020, filed 14 Aug 2020.